沽空銷售量（含暗池和交易所數據）
INBX / Inhibrx Biosciences, Inc.的沽空交易量如以下圖表所示。沽空交易量顯示了各個交易場所中被標記為沽空交易的交易數量。欲了解更多有關如何解讀此數據的信息，請閱讀FINRA提供的此 資訊通知。
- FINRA 沽空交易量
- FINRA報告的場外空頭交易股票數量， 包括豁免和非豁免。
- CBOE 沽空交易量
- CBOE報告的空頭交易股票數量。
- PSX/BX 沽空交易量
- NASDAQ報告的在PSX/BX交易場所空頭交易股票數量。
- 整體沽空交易量
- FINRA沽空交易量 + CBOE沽空交易量 + PSX/BX沽空交易量。
- 整體總交易量
- FINRA總交易量 + CBOE總交易量 + PSX/BX總交易量。
- 整體沽空交易量比率
- 整體沽空交易量 / 整體總交易量
更新頻率：每日收盤後
| 市場日期 | FINRA 沽空交易量 |
PSX/BX 沽空交易量 |
整體 沽空交易量 |
整體 總交易量 |
整體 沽空比率 |
||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | 99,354 | + | 100 | = | 99,454 | / | 140,859 | = | 70.61 |
| 2026-06-04 | 102,107 | + | = | / | = | ||||
| 2026-06-03 | 80,055 | + | 700 | = | 80,755 | / | 135,606 | = | 59.55 |
| 2026-06-02 | 90,976 | + | 2,015 | = | 92,991 | / | 146,186 | = | 63.61 |
| 2026-06-01 | 70,948 | + | 1,400 | = | 72,348 | / | 101,133 | = | 71.54 |
| 2026-05-29 | 61,168 | + | 200 | = | 61,368 | / | 79,815 | = | 76.89 |
| 2026-05-28 | 93,667 | + | 100 | = | 93,767 | / | 110,966 | = | 84.50 |
| 2026-05-27 | 64,352 | + | 468 | = | 64,820 | / | 82,712 | = | 78.37 |
| 2026-05-26 | 41,238 | + | 200 | = | 41,438 | / | 65,757 | = | 63.02 |
| 2026-05-22 | 236,053 | + | 9,364 | = | 245,417 | / | 266,131 | = | 92.22 |
| 2026-05-21 | 64,911 | + | 1,158 | = | 66,069 | / | 101,891 | = | 64.84 |
| 2026-05-20 | 76,024 | + | 929 | = | 76,953 | / | 232,081 | = | 33.16 |
| 2026-05-19 | 73,493 | + | 1,273 | = | 74,766 | / | 112,266 | = | 66.60 |
| 2026-05-18 | 101,163 | + | 6,704 | = | 107,867 | / | 167,971 | = | 64.22 |
| 2026-05-15 | 106,821 | + | 3,271 | = | 110,092 | / | 140,773 | = | 78.21 |
| 2026-05-14 | 101,134 | + | 1,003 | = | 102,137 | / | 135,534 | = | 75.36 |
| 2026-05-13 | 141,252 | + | 1,000 | = | 142,252 | / | 242,003 | = | 58.78 |
| 2026-05-12 | 352,758 | + | 4,148 | = | 356,906 | / | 616,608 | = | 57.88 |
| 2026-05-11 | 266,852 | + | 5,400 | = | 272,252 | / | 447,672 | = | 60.81 |
| 2026-05-08 | 81,703 | + | 500 | = | 82,203 | / | 166,692 | = | 49.31 |
